title: Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
authors.affiliation: Department of Clinical Neurosciences, Psychiatry and Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alta.
authors.forename: Tamara
authors.initials: T
authors.lastname: Pringsheim
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002648:Child; D003000:Clonidine / Q000008:administration & dosage / Q000494:pharmacology*; D015897:Comorbidity; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D020323:Tics / Q000188:drug therapy* / Q000453:epidemiology; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003000:Clonidine